DELFI Diagnostics’ Post

Today, we published our H1 2024 Interim Results, showing the strong commercial momentum we're making across all of our key regions – the UK, US and France. Highlights include: 🔹 Continued strong demand for our CDMO services with an increase in the number of late-stage programmes; currently supporting late-stage activities for 4 clients preparing for commercial launch of CAR-T products 🔹Successfully onboarded multiple new clients, including signing 7 early-stage AAV programmes in the US 🔹Continued execution of our “One OXB” strategy with global integration progressing across UK, US and French operations 🔹Existing near-term and medium-term financial guidance reiterated, supported by positive growth trajectory of the business   Read the full statement here: https://lnkd.in/eF3btfVC   The #OXB management team, led by our CEO, Dr. Frank Mathias, CFO, Dr. Lucinda Crabtree, and CCO, Dr. Sébastien Ribault, will be hosting a hybrid analyst briefing and Q&A session today at 13:00 BST / 8:00 EST. #CDMO #CellAndGeneTherapy #ViralVectors #AdvancedTherapies

Today we released updated medium-term financial guidance following the recent completion of our acquisition of ABL Europe, as well as an update on trading for the year ended 31 December 2023, highlighting our progress towards delivering our pure-play CDMO strategy.   Highlights from the announcement include:   🔹 Three-year revenue CAGR increased to more than 35%, up from prior guidance of more than 30%   🔹  Projected FY2024 revenue range of £126 million to £134 million, reflecting the successful integration of ABL Europe and anticipated growth from new and existing client programmes   🔹 FY2023 revenues and EBITDA expected to be in line with guidance provided at the Interim Results   Read more in our release here: https://lnkd.in/edUmRZXp   #CDMO #CellAndGeneTherapy #ViralVectors

What if patient charts were streamlined, automated, and significantly easier to prepare? DAGCAP is a modular, interoperable, comprehensive end-to-end workflow aimed at decreasing chart curation effort by 90% while maintaining human-level accuracy.

To deliver better clinical trial results, you need to create a better patient experience. Next-gen clinical trials put patients at the center, leveraging data and analytics, digital technologies and connected devices to identify participants, improve accessibility, accelerate enrolment and drive engagement. Read our Capgemini point of view https://bit.ly/49J9B5N and learn how your organization can break through challenges to create breakthrough innovations.

Our December #newsletter is here! Get the latest #insights from the Capital Rx team, access helpful resources, and much more! We hope everyone is having a healthy and happy Holiday Season; we'll see you in the new year. #CapitalRxNewsletter

Discover how Access Healthcare partnered with a diagnostics leader to revolutionize its revenue cycle. Our collaborative efforts resulted in substantial cost reductions and streamlined accounts receivable processes, paving the way for financial success. Explore the journey and outcomes in this impactful case study: https://bit.ly/3ugRFjG #accountsreceivable #revenuecyclemanagement #strategicpartnership #financialsuccess

Discover how Access Healthcare partnered with a diagnostics leader to revolutionize its revenue cycle. Our collaborative efforts resulted in substantial cost reductions and streamlined accounts receivable processes, paving the way for financial success. Explore the journey and outcomes in this impactful case study: https://bit.ly/42C5QwF #accountsreceivable #revenuecyclemanagement #strategicpartnership #financialsuccess

Discover how Access Healthcare partnered with a diagnostics leader to revolutionize its revenue cycle. Our collaborative efforts resulted in substantial cost reductions and streamlined accounts receivable processes, paving the way for financial success. Explore the journey and outcomes in this impactful case study: https://bit.ly/3SCmGI6 #accountsreceivable #revenuecyclemanagement #strategicpartnership #financialsuccess

Discover how Access Healthcare partnered with a diagnostics leader to revolutionize its revenue cycle. Our collaborative efforts resulted in substantial cost reductions and streamlined accounts receivable processes, paving the way for financial success. Explore the journey and outcomes in this impactful case study: https://bit.ly/3SEVmcj #accountsreceivable #revenuecyclemanagement #strategicpartnership #financialsuccess

This morning, I had the opportunity to join Jamey Mock, our CFO, and Lavina Talukdar, our Senior VP of Investor Relations, to recap our fourth quarter and fiscal year 2023 earnings report and discuss what we are looking forward to in 2024. Watch our latest IR Insights video below to hear more about how #TeamModerna is writing our next chapter on our mission to deliver the greatest possible impact to people through #mRNA medicines! ⬇